The present invention relates to a pharmaceutical combination comprising a PI3K/mTOR inhibitor selected from the compounds of Formula (I) (as described herein) or pharmaceutically acceptable salts or solvates thereof and one or more anti-proliferative agents pharmaceutical compositions containing said the compounds of Formula (I) and one or more anti-proliferative agents and use of the said combination in the treatment of proliferative diseases or disorders.